Pediatric sleep-disordered breathing remains under-diagnosed in Australia. The condition is more common than parents and primary care clinicians often realise, the presenting symptoms are different from the adult presentation, and the diagnostic pathway has gaps that the 2026 system hasn’t fully closed.

The clinical picture: pediatric obstructive sleep apnoea typically presents differently from adult OSA. Loud snoring is a common feature, but the daytime presentation is often behavioural rather than purely sleep-related. Children with significant OSA often present as inattentive, hyperactive, irritable, or behaviourally dysregulated. The overlap with ADHD-like presentation is real and diagnostically important. Some children carrying ADHD diagnoses have substantive untreated sleep-disordered breathing as the primary cause of their daytime symptoms, and treating the breathing condition resolves the apparent attention difficulties.

The prevalence in Australian children is broadly consistent with international figures: meaningful sleep-disordered breathing affects somewhere in the range of 1-4 percent of children, with simple primary snoring affecting a larger group. The peak presenting ages cluster around the 3-7 year range when adenotonsillar tissue is at its largest relative to airway dimensions. Some children present earlier or later, and some patterns relate to craniofacial structure, obesity, or specific neurodevelopmental conditions.

The diagnostic pathway in Australia has improved over the past decade but retains real gaps. The gold-standard investigation remains in-laboratory polysomnography in a paediatric sleep unit. Australian capacity for paediatric polysomnography remains constrained, particularly outside major capital cities. Wait times for non-urgent investigations are commonly months. Patients in regional areas face larger access challenges still.

Home-based sleep testing in children is more limited than in adults. The validation data for paediatric home testing is thinner than the adult equivalent, and for most diagnostic decisions the in-lab study remains preferred. A small number of paediatric sleep services have started using home oximetry as a screening tool, with subsequent in-lab confirmation, which improves the front-end of the pathway in some settings.

The treatment pathway depends on the specific diagnosis and the severity. For most children with adenotonsillar enlargement as the primary contributor, adenotonsillectomy remains the first-line treatment with strong evidence for symptom resolution in the majority of cases. For obese children, weight management is part of the picture but is rarely sufficient on its own. For children with craniofacial issues, a multidisciplinary approach involving paediatric ENT, orthodontics, and sleep medicine produces better outcomes than single-discipline management.

The post-surgical follow-up question deserves more attention than it commonly gets. A meaningful minority of children remain symptomatic after adenotonsillectomy, and the systematic post-surgical reassessment pathway is uneven across Australian centres. Children whose families assumed surgery would resolve the issue can carry residual sleep-disordered breathing for years before re-presenting. Better post-operative reassessment cadence would catch these earlier.

CPAP therapy in children is more complex than in adults. The interface fit for paediatric faces is genuinely difficult. Adherence support requires specialist paediatric sleep nursing input. The number of Australian paediatric sleep services with strong CPAP support capability is small, and families often travel significant distances for ongoing support. The capability gap here is real and well-known to the workforce involved.

The behavioural and developmental implications of untreated paediatric OSA are increasingly well-characterised. Effects on cognitive development, school performance, behaviour, and growth are documented across the literature. The case for systematic identification and treatment is strong, and the cost-benefit calculation in Australian public-health terms is favourable. The constraint is workforce and infrastructure capacity rather than evidence.

For Australian families with concerns about a child’s sleep, the practical pathway is GP assessment followed by paediatric ENT or sleep medicine referral if the picture warrants it. Parents should be aware that “loud snoring in children” is not normal, behavioural symptoms can be sleep-related, and the diagnostic pathway is real but slower than ideal. Persistence with the system, and willingness to ask for referral if initial reassurance doesn’t match the family observation, is sometimes necessary.

The 2026 system isn’t broken but it isn’t where it needs to be. The longer-term workforce planning conversations are happening, and the next decade should see a more capable Australian paediatric sleep service if the current investment direction continues. Families dealing with this in the meantime navigate a real but imperfect pathway.